AI
ARK Investment Management LLC disclosed a 10.4% stake in CRSP
ARK Investment Management LLC reported owning 10.4% of CRISPR Therapeutics AG (CRSP) (10,056,844 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G